As the FTSE 100 index faces headwinds from weak trade data out of China and faltering global cues, investors are closely watching for opportunities in a challenging market environment. In such conditions, identifying stocks that might be trading below their intrinsic value can offer potential for growth as these companies may have strong fundamentals despite current market pressures.
|
Name |
Current Price |
Fair Value (Est) |
Discount (Est) |
|
Motorpoint Group (LSE:MOTR) |
£1.39 |
£2.66 |
47.7% |
|
Knights Group Holdings (AIM:KGH) |
£1.89 |
£3.67 |
48.5% |
|
Informa (LSE:INF) |
£8.94 |
£17.04 |
47.5% |
|
Hochschild Mining (LSE:HOC) |
£5.705 |
£11.28 |
49.4% |
|
Fevertree Drinks (AIM:FEVR) |
£8.42 |
£15.87 |
46.9% |
|
CAB Payments Holdings (LSE:CABP) |
£0.651 |
£1.29 |
49.5% |
|
Barratt Redrow (LSE:BTRW) |
£3.779 |
£7.20 |
47.5% |
|
AOTI (AIM:AOTI) |
£0.375 |
£0.74 |
49.6% |
|
Anglo Asian Mining (AIM:AAZ) |
£2.725 |
£5.20 |
47.6% |
|
Advanced Medical Solutions Group (AIM:AMS) |
£2.22 |
£4.32 |
48.6% |
We’ll examine a selection from our screener results.
Overview: Tristel plc develops, manufactures, and sells infection prevention products across the United Kingdom, Australia, Germany, Western Europe, and internationally with a market cap of £200.01 million.
Operations: The company’s revenue primarily comes from Hospital Medical Device Decontamination (£40.38 million) and Hospital Environmental Surface Disinfection (£3.69 million).
Estimated Discount To Fair Value: 17.6%
Tristel’s recent expansion into the US market with its FDA-cleared Tristel ULT™ product could enhance revenue streams, aligning with forecasts of 8.9% annual revenue growth, outpacing the UK market average. Despite trading at £4.18, below its fair value estimate of £5.07, the undervaluation isn’t substantial. Earnings are projected to grow at 15.2% annually, surpassing UK market growth rates but not significantly high overall; however, dividends remain inadequately covered by earnings.
Overview: Mitie Group plc, along with its subsidiaries, offers facilities management and professional services in the UK and internationally, with a market cap of £2.14 billion.
Operations: The company’s revenue is derived from Business Services (£2.43 billion) and Technical Services (£2.04 billion).
Estimated Discount To Fair Value: 27.9%
